Imperial College London

DrMarioFalchi

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 6519m.falchi

 
 
//

Location

 

Burlington-Danes Building, Room E303Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Publication Type
Year
to

111 results found

Sanna M, Li X, Visconti A, Freidin MB, Sacco C, Ribero S, Hysi P, Bataille V, Han J, Falchi Met al., 2021, Looking for Sunshine: Genetic Predisposition to Sun Seeking in 265,000 Individuals of European Ancestry, JOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol: 141, Pages: 779-786, ISSN: 0022-202X

Journal article

Visconti A, Bataille V, Rossi N, Kluk J, Murphy R, Puig S, Nambi R, Bowyer RCE, Murray B, Bournot A, Wolf J, Ourselin S, Steves CJ, Spector TD, Falchi Met al., 2021, Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection, BRITISH JOURNAL OF DERMATOLOGY, Vol: 184, Pages: 880-887, ISSN: 0007-0963

Journal article

Sudre CH, Lee KA, Lochlainn MN, Varsavsky T, Murray B, Graham MS, Menni C, Modat M, Bowyer RCE, Nguyen LH, Drew DA, Joshi AD, Ma W, Guo C-G, Lo C-H, Ganesh S, Buwe A, Pujol JC, du Cadet JL, Visconti A, Freidin MB, Moustafa JSE-S, Falchi M, Davies R, Gomez MF, Fall T, Cardoso MJ, Wolf J, Franks PW, Chan AT, Spector TD, Steves CJ, Ourselin Set al., 2021, Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app, SCIENCE ADVANCES, Vol: 7, ISSN: 2375-2548

Journal article

Bar N, Korem T, Weissbrod O, Zeevi D, Rothschild D, Leviatan S, Kosower N, Lotan-Pompan M, Weinberger A, Le Roy CI, Menni C, Visconti A, Falchi M, Spector TD, Adamski J, Franks PW, Pedersen O, Segal Eet al., 2020, A reference map of potential determinants for the human serum metabolome, NATURE, Vol: 588, Pages: 135-140, ISSN: 0028-0836

Journal article

Bataille V, Visconti A, Rossi N, Murray B, Bournot A, Wolf J, Ourselin S, Steves C, Spector TD, Falchi Met al., 2020, Diagnostic value of skin manifestation of SARS-CoV-2 infection

<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 causes multiple immune-related reactions at various stages of the disease. The wide variety of skin presentations has delayed linking these to the virus. Previous studies had attempted to look at the prevalence and timing of SARS-COV-2 rashes but were based on mostly hospitalized severe cases and had little follow up. Using data collected on a subset of 336,847 eligible UK users of the COVID Symptom Study app, we observed that 8.8% of the swab positive cases (total: 2,021 subjects) reported either a body rash or an acral rash, compared to 5.4% of those with a negative swab test (total: 25,136). Together, these two skin presentations showed an odds ratio (OR) of 1.67 (95% confidence interval [CI]: 1.41-1.96) for being swab positive. Skin rashes were also predictive in the larger untested group of symptomatic app users (N=54,652), as 8.2% of those who had reported at least one classical COVID-19 symptom, <jats:italic>i</jats:italic>.<jats:italic>e</jats:italic>., fever, persistent cough, and/or anosmia, also reported a rash. Data from an independent online survey of 11,546 respondents with a rash showed that in 17% of swab positive cases, the rash was the initial presentation. Furthermore, in 21%, the rash was the only clinical sign. Skin rashes cluster with other COVID-19 symptoms, are predictive of a positive swab test and occur in a significant number of cases, either alone or before other classical symptoms. Recognising rashes is important in identifying new and earlier COVID-19 cases.</jats:p>

Journal article

Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, Ganesh S, Varsavsky T, Cardoso MJ, Moustafa JSE-S, Visconti A, Hysi P, Bowyer RCE, Mangino M, Falchi M, Wolf J, Ourselin S, Chan AT, Steves CJ, Spector TDet al., 2020, Real-time tracking of self-reported symptoms to predict potential COVID-19, NATURE MEDICINE, Vol: 26, Pages: 1037-+, ISSN: 1078-8956

Journal article

Greto VL, Cvetko A, Štambuk T, Dempster NJ, Kifer D, Deriš H, Cindrić A, Vučković F, Falchi M, Gillies RS, Tomlinson JW, Gornik O, Sgromo B, Spector TD, Menni C, Geremia A, Arancibia-Cárcamo CV, Lauc Get al., 2020, Extensive weight loss can reduce immune age by altering IgG N-glycosylation

<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Obesity is a major global health problem, and is associated with increased cardiometabolic morbidity and mortality. Protein glycosylation is a frequent postranslational modification, highly responsive to numerous pathophysiological conditions and ageing. The prospect of biological age reduction, by reverting glycosylation changes through metabolic intervention, opens many possibilities. We have investigated whether weight loss interventions affect inflammation- and ageing-associated IgG glycosylation changes, in a longitudinal cohort of bariatric surgery patients. To support potential findings, BMI-related glycosylation changes were monitored in a longitudinal twins cohort.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>IgG N-glycans were chromatographically profiled in 37 obese patients, subjected to low-calorie diet, followed by bariatric surgery, across multiple timepoints. Similarly, plasma-derived IgG N-glycan traits were longitudinally monitored in 1,680 participants from the TwinsUK cohort.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Low-calorie diet induced a marked decrease in the levels of IgG N-glycans with bisecting GlcNAc, whose higher levels are usually associated with ageing and inflammatory conditions. Bariatric surgery resulted in extensive alterations of the IgG glycome that accompanied progressive weight loss during one-year follow-up. We observed a significant increase in digalactosylated and sialylated glycans, and a substantial decrease in agalactosylated and core fucosylated IgG glycans. In general, this IgG glycan profile is associated with a younger biological age and reflects an enhanced anti-inflammatory IgG potential. Loss of BMI over a 20 year period in the TwinsUK cohort validated a weight loss-assoc

Journal article

Williams FMK, Freidin MB, Mangino M, Couvreur S, Visconti A, Bowyer RCE, Le Roy CI, Falchi M, Sudre C, Davies R, Hammond C, Menni C, Steves CJ, Spector TDet al., 2020, Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable

<jats:title>Abstract</jats:title><jats:p>Susceptibility to infection such as SARS-CoV-2 may be influenced by host genotype. TwinsUK volunteers (n=2633) completing the C-19 Covid symptom tracker app allowed classical twin studies of covid-19 symptoms including predicted covid-19, a symptom-based algorithm predicting true infection derived in app users tested for SARS-CoV-2. We found heritability for fever = 41 (95% confidence intervals 12-70)%; anosmia 47 (27-67)%; delirium 49 (24-75)%; and predicted covid-19 gave heritability = 50 (29-70)%.</jats:p>

Journal article

Menni C, Valdes AM, Freidin MB, Ganesh S, El-Sayed Moustafa JS, Visconti A, Hysi P, Bowyer RCE, Mangino M, Falchi M, Wolf J, Steves CJ, Spector TDet al., 2020, Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection

<jats:title>Abstract</jats:title><jats:sec><jats:title>Importance</jats:title><jats:p>A strategy for preventing further spread of the ongoing COVID-19 epidemic is to detect infections and isolate infected individuals without the need of extensive bio-specimen testing.</jats:p></jats:sec><jats:sec><jats:title>Objectives</jats:title><jats:p>Here we investigate the prevalence of loss of smell and taste among COVID-19 diagnosed individuals and we identify the combination of symptoms, besides loss of smell and taste, most likely to correspond to a positive COVID-19 diagnosis in non-severe cases.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Community survey.</jats:p></jats:sec><jats:sec><jats:title>Setting and Participants</jats:title><jats:p>Subscribers of RADAR COVID-19, an app that was launched for use among the UK general population asking about COVID-19 symptoms.</jats:p></jats:sec><jats:sec><jats:title>Main Exposure</jats:title><jats:p>Loss of smell and taste.</jats:p></jats:sec><jats:sec><jats:title>Main Outcome Measures</jats:title><jats:p>COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Between 24 and 29 March 2020, 1,573,103 individuals reported their symptoms via the app; 26% reported suffering from one or more symptoms of COVID-19. Of those, n=1702 reported having had a RT-PCR COVID-19 test and gave full report on symptoms including loss of smell and taste; 579 were positive and 1123 negative. In this subset, we find that loss of smell and taste were present in 59% of COVID-19 positive individuals compared to 18% of those negative to the test, yielding an odds ratio (OR) of COVID-19 diagnosis of OR[95%CI]=6.59[5.25; 8.27], P= 1.90×10<jats:sup>&minus

Journal article

Visconti A, Ribero S, Sanna M, Spector TD, Bataille V, Falchi Met al., 2020, Body site-specific genetic effects influence naevus count distribution in women, PIGMENT CELL & MELANOMA RESEARCH, Vol: 33, Pages: 326-333, ISSN: 1755-1471

Journal article

Suhre K, Trbojevic-Akmacic I, Ugrina I, Mook-Kanamori DO, Spector T, Graumann J, Lauc G, Falchi Met al., 2019, Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome, METABOLITES, Vol: 9

Journal article

Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Liu F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram MA, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW, Kayser M, Hunter DJ, Bishop JAN, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martin NG, Lee JE, Brossard M, Moses EK, Song F, Kumar R, Easton DF, Pharoah PDP, Swerdlow AJ, Kypreou KP, Harland M, Randerson-Moor J, Akslen LA, Andresen PA, Avril M-F, Azizi E, Scarra GB, Brown KM, Debniak T, Elder DE, Fang S, Friedman E, Galan P, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Helsing P, Hocevar M, Hoiom V, Ingvar C, Kanetsky PA, Chen WV, Landi MT, Lang J, Lathrop GM, Lubinski J, Mackie RM, Mann GJ, Molven A, Novakovic S, Olsson H, Puig S, Puig-Butille JA, Radford-Smith GL, van der Stoep N, van Doorn R, Whiteman DC, Craig JE, Schadendorf D, Simms LA, Burdon KP, Nyholt DR, Pooley KA, Orr N, Stratigos AJ, Cust AE, Ward SV, Schulze H-J, Dunning AM, Demenais F, Amos CIet al., 2019, Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (vol 9, 4774, 2018), NATURE COMMUNICATIONS, Vol: 10, ISSN: 2041-1723

Journal article

Schena FP, Serino G, Sallustio F, Falchi M, Cox SNet al., 2018, Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions, NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol: 33, Pages: 2101-2112, ISSN: 0931-0509

Journal article

Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Lui F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram AM, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW, Kayser M, Hunter DJ, Bishop JAN, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martins NGet al., 2018, Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways, NATURE COMMUNICATIONS, Vol: 9, ISSN: 2041-1723

Journal article

Martin TC, Visconti A, Spector TD, Falchi Met al., 2018, Conducting metagenomic studies in microbiology and clinical research, Applied Microbiology and Biotechnology, Vol: 102, Pages: 8629-8646, ISSN: 0175-7598

Owing to the increased cost-effectiveness of high-throughput technologies, the number of studies focusing on the human microbiome and its connections to human health and disease has recently surged. However, best practices in microbiology and clinical research have yet to be clearly established. Here, we present an overview of the challenges and opportunities involved in conducting a metagenomic study, with a particular focus on data processing and analytical methods.

Journal article

Sette G, Salvati V, Giordani I, Pilozzi E, Quacquarini D, Duranti E, De Nicola F, Pallocca M, Fanciulli M, Falchi M, Pallini R, De Maria R, Eramo Aet al., 2018, Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells, INTERNATIONAL JOURNAL OF CANCER, Vol: 143, Pages: 88-99, ISSN: 0020-7136

Journal article

Visconti A, Martin TC, Falchi M, 2018, YAMP: a containerized workflow enabling reproducibility in metagenomics research, GIGASCIENCE, Vol: 7, ISSN: 2047-217X

Journal article

Hysi PG, Valdes AM, Liu F, Furlotte NA, Evans DM, Bataille V, Visconti A, Hemani G, McMahon G, Ring SM, Smith GD, Duffy DL, Zhu G, Gordon SD, Medland SE, Lin BD, Willemsen G, Hottenga JJ, Vuckovic D, Girotto G, Gandin I, Sala C, Concas MP, Brumat M, Gasparini P, Toniolo D, Cocca M, Robino A, Yazar S, Hewitt AW, Chen Y, Zeng C, Uitterlinden AG, Ikram MA, Hamer MA, van Duijn CM, Nijsten T, Mackey DA, Falchi M, Boomsma DI, Martin NG, Hinds DA, Kayser M, Spector TDet al., 2018, Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability, NATURE GENETICS, Vol: 50, Pages: 652-+, ISSN: 1061-4036

Journal article

Felli M, Falchi M, 2018, Propeller wake evolution mechanisms in oblique flow conditions, JOURNAL OF FLUID MECHANICS, Vol: 845, Pages: 520-559, ISSN: 0022-1120

Journal article

Zaghlool SB, Mook-Kanamori DO, Kader S, Stephan N, Halama A, Engelke R, Sarwath H, Al-Dous EK, Mohamoud YA, Roemisch-Margl W, Adamski J, Kastenmueller G, Friedrich N, Visconti A, Tsai P-C, Spector T, Bell JT, Falchi M, Wahl A, Waldenberger M, Peters A, Gieger C, Pezer M, Lauc G, Graumann J, Malek JA, Suhre Ket al., 2018, Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation, HUMAN MOLECULAR GENETICS, Vol: 27, Pages: 1106-1121, ISSN: 0964-6906

Journal article

Messina V, Valtieri M, Rubio M, Falchi M, Mancini F, Mayor A, Alano P, Silvestrini Fet al., 2018, Gametocytes of the Malaria Parasite Plasmodium falciparum Interact With and Stimulate Bone Marrow Mesenchymal Cells to Secrete Angiogenetic Factors, FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, Vol: 8, ISSN: 2235-2988

Journal article

Filippi L, Fiorini P, Catarzi S, Berti E, Padrini L, Landucci E, Donzelli G, Bartalena L, Fiorentini E, Boldrini A, Giampietri M, Scaramuzzo RT, la Marca G, Della Bona ML, Fiori S, Tinelli F, Bancale A, Guzzetta A, Cioni G, Pisano T, Falchi M, Guerrini Ret al., 2018, Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study, JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, Vol: 31, Pages: 973-980, ISSN: 1476-7058

Journal article

Solimena M, Schulte AM, Marselli L, Ehehalt F, Richter D, Kleeberg M, Mziaut H, Knoch K-P, Parnis J, Bugliani M, Siddiq A, Jörns A, Burdet F, Liechti R, Suleiman M, Margerie D, Syed F, Distler M, Grützmann R, Petretto E, Moreno-Moral A, Wegbrod C, Sönmez A, Pfriem K, Friedrich A, Meinel J, Wollheim CB, Baretton GB, Scharfmann R, Nogoceke E, Bonifacio E, Sturm D, Meyer-Puttlitz B, Boggi U, Saeger H-D, Filipponi F, Lesche M, Meda P, Dahl A, Wigger L, Xenarios I, Falchi M, Thorens B, Weitz J, Bokvist K, Lenzen S, Rutter GA, Froguel P, von Bülow M, Ibberson M, Marchetti Pet al., 2017, Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes., Diabetologia, Vol: 61, Pages: 641-657, ISSN: 0012-186X

AIMS/HYPOTHESIS: Pancreatic islet beta cell failure causes type 2 diabetes in humans. To identify transcriptomic changes in type 2 diabetic islets, the Innovative Medicines Initiative for Diabetes: Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in Diabetes (IMIDIA) consortium ( www.imidia.org ) established a comprehensive, unique multicentre biobank of human islets and pancreas tissues from organ donors and metabolically phenotyped pancreatectomised patients (PPP). METHODS: Affymetrix microarrays were used to assess the islet transcriptome of islets isolated either by enzymatic digestion from 103 organ donors (OD), including 84 non-diabetic and 19 type 2 diabetic individuals, or by laser capture microdissection (LCM) from surgical specimens of 103 PPP, including 32 non-diabetic, 36 with type 2 diabetes, 15 with impaired glucose tolerance (IGT) and 20 with recent-onset diabetes (<1 year), conceivably secondary to the pancreatic disorder leading to surgery (type 3c diabetes). Bioinformatics tools were used to (1) compare the islet transcriptome of type 2 diabetic vs non-diabetic OD and PPP as well as vs IGT and type 3c diabetes within the PPP group; and (2) identify transcription factors driving gene co-expression modules correlated with insulin secretion ex vivo and glucose tolerance in vivo. Selected genes of interest were validated for their expression and function in beta cells. RESULTS: Comparative transcriptomic analysis identified 19 genes differentially expressed (false discovery rate ≤0.05, fold change ≥1.5) in type 2 diabetic vs non-diabetic islets from OD and PPP. Nine out of these 19 dysregulated genes were not previously reported to be dysregulated in type 2 diabetic islets. Signature genes included TMEM37, which inhibited Ca2+-influx and insulin secretion in beta cells, and ARG2 and PPP1R1A, which promoted insulin secretion. Systems biology approaches identified HNF1A, PDX1 and REST as drivers o

Journal article

Sacco C, Viroli C, Falchi M, 2017, A statistical test for detecting parent-of-origin effects when parental information is missing, STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY, Vol: 16, Pages: 275-289, ISSN: 2194-6302

Journal article

Romano A, Gallelli CA, Koczwara JB, Braegger FE, Vitalone A, Falchi M, Di Bonaventura MVM, Cifani C, Cassano T, Lutz TA, Gaetani Set al., 2017, Role of the area postrema in the hypophagic effects of oleoylethanolamide, PHARMACOLOGICAL RESEARCH, Vol: 122, Pages: 20-34, ISSN: 1043-6618

Journal article

Medjeral-Thomas NR, Lomax-Browne HJ, Beckwith H, Willicombe M, McLean AG, Brookes P, Pusey CD, Falchi M, Cook HT, Pickering MCet al., 2017, Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy, Kidney International, Vol: 92, Pages: 942-952, ISSN: 0085-2538

IgA nephropathy (IgAN) is a common cause of chronic kidney disease and end-stage renal failure, especially in young people. Due to a wide range of clinical outcomes and difficulty in predicting response to immunosuppression, we need to understand why and identify which patients with IgAN will develop progressive renal impairment. A deletion polymorphism affecting the genes encoding the complement factor H-related protein (FHR)-1 and FHR-3 is robustly associated with protection against IgAN. Some FHR proteins, including FHR-1 and FHR-5, antagonize the ability of complement factor H (fH), the major negative regulator of the complement alternative pathway, to inhibit complement activation on surfaces, a process termed fH deregulation. From a large cohort of patients, we demonstrated that plasma FHR-1 and the FHR-1/fH ratio were elevated in IgAN and associated with progressive disease. Plasma FHR-1 negatively correlated with eGFR but remained elevated in patients with IgAN with normal eGFR. Serum FHR5 was slightly elevated in IgAN but did not correlate with eGFR. Neither FHR5 levels nor the FHR-5/fH ratio was associated with progressive disease. However, higher serum FHR-5 levels were associated with a lack of response to immunosuppression, the presence of endocapillary hypercellularity, and histology scores of disease severity (the Oxford Classification MEST score). Thus, FHR-1 and FHR-5 have a role in IgAN disease progression.

Journal article

Parlato S, De Ninno A, Molfetta R, Toschi E, Salerno D, Mencattini A, Romagnoli G, Fragale A, Roccazzello L, Buoncervello M, Canini I, Bentivegna E, Falchi M, Bertani FR, Gerardino A, Martinelli E, Natale C, Paolini R, Businaro L, Gabriele Let al., 2017, 3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells, SCIENTIFIC REPORTS, Vol: 7, ISSN: 2045-2322

Journal article

Saeed S, Bonnefond A, Manzoor J, Shabbir F, Ayesha H, Philippe J, Durand E, Crouch H, Sand O, Ali M, Butt T, Rathore AW, Falchi M, Arslan M, Froguel Pet al., 2017, Genetic Variants in LEP, LEPR, and MC4R Explain 30% of Severe Obesity in Children from a Consanguineous Population (vol 23, pg 1687, 2015), OBESITY, Vol: 25, Pages: 807-807, ISSN: 1930-7381

Journal article

Arredouani A, Stocchero M, Culeddu N, Moustafa JE-S, Tichet J, Balkau B, Brousseau T, Manca M, Falchi Met al., 2017, Metabolomic Profile of Low-Copy Number Carriers at the Salivary alpha-Amylase Gene Suggests a Metabolic Shift Toward Lipid-Based Energy Production (vol 65, pg 3362, 2016), DIABETES, Vol: 66, Pages: 1097-1097, ISSN: 0012-1797

Journal article

Anton Puig-Butille J, Gimenez-Xavier P, Visconti A, Nsengimana J, Garcia-Garcia F, Tell-Marti G, Jose Escamez M, Newton-Bishop J, Bataille V, del Rio M, Dopazo J, Falchi M, Puig Set al., 2017, Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis, ONCOTARGET, Vol: 8, Pages: 11589-11599

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: respub-action=search.html&id=00558995&limit=30&person=true